AXQ Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$169K Sell
10,436
-3,691
-26% -$58.9K 0.02% 785
2026
Q2
$240K Sell
14,127
-4,948
-26% -$79K 0.03% 672
2026
Q1
$283K Sell
19,075
-1,562
-8% -$22.8K 0.04% 621
2025
Q4
$329K Sell
20,637
-375
-2% -$5.32K 0.07% 409
2025
Q3
$232K Buy
+21,012
New +$229K 0.09% 406
2023
Q3
– Sell
-19,100
Closed -$185K – 465
2023
Q2
$185K Buy
+19,100
New +$198K 0.23% 213

Other funds holding AUPH

AXQ Capital's AUPH Position: Q3 2026 in Review

AXQ Capital reduced its Aurinia Pharmaceuticals (AUPH) stake by 26% in Q3 2026, selling an estimated $58.9K and leaving 10,436 shares worth $169K. The position accounts for 0.02% of the portfolio, ranked #785.

AXQ Capital first reported a position in AUPH in Q2 2023 and has held it in 6 quarters since. The position peaked at $329K in Q4 2025. 276 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • AXQ Capital held 10,436 shares of Aurinia Pharmaceuticals worth $169K as of Q3 2026.
  • AXQ Capital sold 3,691 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $58.9K.
  • Aurinia Pharmaceuticals made up 0.02% of AXQ Capital's portfolio in Q3 2026, its #785 holding.
  • AXQ Capital first reported a position in Aurinia Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • AXQ Capital's Aurinia Pharmaceuticals position peaked at $329K in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.